Navigation Links
Chiltern Opens Office in Budapest, Hungary
Date:6/29/2009

LONDON, June 30 /PRNewswire/ -- Chiltern International Limited (Chiltern), a global clinical research organization (CRO) announced that it has opened a new office in Budapest, Hungary.

Dr. Attila Lorinczi will lead this operation. Dr. Lorinczi is a member of the Hungarian Medical Society and the Society of Hungarian Urologists. Dr. Lorinczi has broad experience in the pharmaceutical industry spanning over 13 years, most recently as a clinical operations manager.

"Hungary and the CEE region continue to provide excellent quality data and good patient recruitment rates," Attila commented. "We expect this to grow further due to the knowledge and expertise of Hungarian investigators and the availability of quality staff."

"Chiltern continues to expand following our recent opening of an office in Belgium," explained Lewis Cameron, Chiltern Executive Vice President for Europe. "Central and Eastern Europe continues to be a key focus for our clinical trials and Hungary is an important component of this region. We are delighted to show our continual regional growth in line with our strategy for increased global coverage."

Company profile

About Chiltern:

Established in 1982, Chiltern is a leading global Contract Research Organization with extensive experience conducting and staffing international Phase I to Phase IV clinical trials across a broad range of therapeutic areas for a wide variety of clients. Chiltern has conducted trials in more than 40 countries and employs 1,400 people in 28 countries. Chiltern provides Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions services. Further information is available at www.chiltern.com. 

    For More Information Contact:


    Stuart McGuire             
'/>"/>
SOURCE  Chiltern International Limited
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 

Related medicine news :

1. Chiltern Expands European Operations With a New Office in Belgium
2. Chiltern Acquires Brazil-Based Clinical Research Organization Vigiun
3. Chiltern and EPS International Hold a Joint Seminar in Tokyo, Japan
4. Chiltern Appoints Jane Turner as Late Phase Director for Europe
5. Chilterns Resourcing Solutions Division Appoints New Managers to Spain and the United Kingdom
6. Chiltern and EPS INTERNATIONAL Enter Into a Global Partnership
7. Chiltern Enhances Its Portfolio of Electronic Data Capture (EDC) Services With the Addition of Hosting and eCRF Design Services for DataLabs (by ClinPhone) and Medidata Rave(R) Certification
8. Chiltern Expands Its Global Reach to Latin America
9. Chiltern Announces New Expansion in Portugal
10. Chiltern Opens a New Office in Russia
11. Chiltern Will Sponsor and Present at the 17th Annual Partnerships With CROs Meeting in Las Vegas, April 14 - 16, 2008.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2013)... May 25, 2013 Life science and ... used to detect and create a new substance with ... and are also known as biotechnology reagents. Such reagents ... and education. , This market is driven by factors ... the field of therapeutics, growth in research and rapid ...
(Date:5/25/2013)... York (PRWEB) May 25, 2013 ... litigation underway in U.S. District Court, Western District of ... According to a Case Management Order issued on ... the filing of contested motions in the Actos bladder ... motions. (In re: Actos Product Liability Litigation, MDL No. ...
(Date:5/25/2013)... The report “Global Food Encapsulation Market (2012 ... Shell Materials, Packaging, & Geography: Trends & Forecasts” ... with analysis and forecasting of the global revenue ... and restraining factors for the global food encapsulation ... The market is segmented and revenue are forecasted ...
(Date:5/25/2013)... 25, 2013 Providing patients with their best ... team of weight management professionals. But, aside from educating patients ... Diet Doc’s hCG diets also provide patients, who ... childhood like bullying, more control over their lives by achieving ... with the underlying factors of weight gain derived from earlier ...
(Date:5/25/2013)... York, New York (PRWEB) May 25, 2013 ... who allegedly suffered serious, life-threatening episodes of internal bleeding while ... litigation underway in U.S. District Court, Southern District of Illinois, ... the Court’s website, 818 Pradaxa side effect claims had ... 2013. That’s up from 705 claims reported by the ...
Breaking Medicine News(10 mins):Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 2Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 3Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 3Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 2Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 3Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 3
... the survival rate of children with sarcoma in ... disease sooner, train cancer pathologists, expand radiation therapy ... and other actions, according to an international study ... findings will be presented at the 42nd Congress ...
... Mo. -- For some women, the effects of breast cancer, ... they leave the hospital. Now, researchers in the University of ... breast cancer patients following chemotherapy and found that their environments ... lives. "A lot of times people get mentally ...
... Elsevier / MC Strategies, a pioneer in providing ... partnered with the Association of periOperative Registered Nurses (AORN) ... Perioperative Collection, the only perioperative-specific set of nursing skills ... Standards and Recommended Practices. Authored ...
... HealthDay Reporter , TUESDAY, Oct. 19 (HealthDay News) -- ... risk of breast cancer, new research finds, but it also ups ... a woman,s chances of dying. A study appearing in the ... Association is at odds with previous observational studies that had ...
... beam therapy is safe and effective and may be ... non-small cell lung cancer (NSCLC) patients, according to a ... Journal of Radiation OncologyBiologyPhysics, the official journal of ... is the number one cause of cancer death for ...
... (HealthDay News) -- Newborn hearing screening leads to better ... problems, new European research finds. In a study ... the Netherlands -- more than 570,000 -- researchers identified ... hearing disorders. They then analyzed the social development, gross ...
Cached Medicine News:Health News:Study identifies barriers to successful treatment of children with sarcoma in low-income countries 2Health News:Women fight the effects of chemotherapy long after treatment ends 2Health News:Elsevier/MC Strategies and AORN launch perioperative nursing skills collection 2Health News:Study Shows HRT Even Riskier Than Thought 2Health News:Study Shows HRT Even Riskier Than Thought 3Health News:Proton therapy safe, effective for early-stage lung cancer patients 2Health News:Newborn Hearing Tests More Effective Than Later Screening 2
(Date:5/23/2013)... 2013  Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: ... based on intellectual property developed and owned by ... foremost medical research center, today announced that its ... funding from the Israeli Ministry of Industry and ... support product development and advance clinical trials. Cell ...
(Date:5/23/2013)... , May 23, 2013  Every day, their baby stopped ... to his lungs. April and Bryan Gionfriddo ... weren,t true. "Quite a few doctors said he ... says April Gionfriddo , about her now ... that would work, we would take it and run with ...
(Date:5/23/2013)... May 23, 2013   Direct to implant, ... is an appropriate option for many women with ... reduce their breast cancer risk, or with breast ... process and a second surgery to insert permanent ... same surgery as mastectomy can be a medically ...
Breaking Medicine Technology:Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3
... ViroPharma Incorporated (Nasdaq: VPHM ) ... has granted ViroPharma an exclusive worldwide license to ... delivery platform using Halozyme,s recombinant human hyaluronidase enzyme ... inhibitor. Additionally, Halozyme has agreed not to grant to ...
... Henry Schein, Inc. (NASDAQ: HSIC ), the ... dental, medical and veterinary practitioners, has been ranked number 317 ... Largest Corporations.  Henry Schein,s net sales reached a record $7.5 ... 500 rankings over the past three years, having been ranked ...
Cached Medicine Technology:ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor 2ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor 3ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor 4ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor 5ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor 6ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor 7Henry Schein Ranks #317 in 2011 Fortune 500 Ranking of America's Largest Corporations 2
Features four-way apron closure for super adjustability to fit staff of all shapes and sizes. Top left and right shoulder closures allow adjustment of armhole size and chest area of apron for close a...
Freedom of movement - plus full circle, maximum radiation protection. No other full circle radiation protection design approaches the level of comfort of the VestSkirt, which divides weight between t...
Use this workhorse apron where 360 of protection from direct and scatter radiation is required....
Bio-Rad's Genetic Systems™ HBsAg EIA 3.0 screening and confirmatory assays offer outstanding sensitivity and early detection of HBV infection, helping to meet your testing criteria....
Medicine Products: